We compared fMRI and cognitive data from nine hormone therapy (HT)-naive women with data from women exposed to either opposed conjugated equine estrogens (CEE) (n ϭ 10) or opposed estradiol (n ϭ 4). Exposure to either form of HT was associated with healthier fMRI response; however, CEE-exposed women exhibited poorer memory performance than either HTnaive or estradiol-exposed subjects. These preliminary findings emphasize the need to characterize differential neural effects of various HTs.
Methods. Subjects came from a pool of 42 women, enrolled as control subjects for a study examining the effects of parental history on risk for developing Alzheimer disease. The 23 (54.8%) eligible subjects had intact ovaries and uterus and were post-menopausal. Mean age was 58.5 years (SD 4.7). At the time of scan, two women were on opposed CEE and two on opposed estradiol. The HT regimens used by participants were standard therapies, initiated around menopause. All participants provided written informed consent. Exclusions for this study are described elsewhere. 4, 5 A three-level HT status variable was created for exploratory analyses. Ten women were exposed to opposed CEE and four to opposed estradiol preparations. Nine women were naive to HT.
The fMRI task is described in detail elsewhere. 4, 5 In brief, subjects were presented with novel and previously learned line drawings. Response to novel items was compared with activation to previously learned pictures. This difference in activation to novel vs previously learned items was the condition of interest in this study. The fMRI scanning procedures and individual subject image analysis are described in a previous publication. 4, 5 Between-group comparisons were constrained to a region of interest (ROI), based on normative activation on this same fMRI task in 77 healthy young and middle-aged adults. 4 Figure E -1 (on the Neurology Web site at www.neurology.org) depicts this mask. The variables of years of exposure and HT status are interrelated for these analyses. Thus, nonparametric Wilcoxon score general linear models 6 were employed to detect an effect of either HT status and years of use simultaneously.
Cognitive task and analyses. Subjects underwent a battery of neuropsychological tests, including a verbal memory test, the Auditory Verbal Learning Test (AVLT). 7 This test is similar to our fMRI task, as such was selected for analysis. In this test, participants were read a list of 15 words five times and asked to recall the words after each presentation and again after short and long delays. Age-corrected scores were obtained using published normative data. 7 As with fMRI data, nonparametric Wilcoxon score general linear models 6 were used to examine the effect of HT status and length of exposure for the three groups.
Results. Demographic, genetic, behavioral, and laboratory data for the three groups, HT naive, CEE exposed, and estradiol exposed, are listed in the table. The groups did not differ on any subject characteristic variable.
Imaging results. The fMRI task evoked hippocampal and inferior temporal lobe activation bilaterally to novel items compared with previously learned items for all participants.
To compare the three groups of women, we used a nonparametric general linear model, combining HT status and years of exposure to estimate activation. Within our ROI, an effect of HT exposure, either CEE or estradiol exposure, was evident bilaterally in the medial temporal lobes. Global maxima for the right was located in the body of the hippocampus (F ϭ 6.76, p ϭ 0.003; x, y, z: 26, Ϫ20, Ϫ16; cluster size ϭ 372). For the left, global maxima was in the ventral posterior temporal lobe (F ϭ 8.10, p ϭ 0.001; x, y, z: Ϫ36, Ϫ38, Ϫ20, cluster size ϭ 143). A 2-mm radius cluster around the global maxima in the right hippocampus was selected to represent the activation patterns for the three groups and is depicted in figure 1 . This representation of activation suggested that the estradiol-and CEE-exposed groups exhibited greater neural response than the HTnaive group.
Cognitive results. Age-corrected AVLT variables for the three groups were subjected to nonparametric general linear modeling, incorporating both HT status and years of exposure ( figure 2 ). The overall model was significant for two of the five AVLT variables examined: the age-corrected standard scores for the total of the learning trials and the long-delay free recall. Estimates of model-implied expected values for each group suggested that the estradiol-exposed group exhibited the best performance, the CEE-exposed group the worst, with the HT-naive group intermediate to the two (total of the learning trials F[3,19] ϭ 8.07, p ϭ 0.001; long-delay free recall F[3,19] ϭ 6.63, p ϭ 0.003).
Discussion. The mechanistic basis for estrogen's neurobiological effects in the brain is well established. 3 In contrast, the WHIMS findings 1,2 revealed an increased risk for cognitive decline and dementia with opposed CEE therapy. These findings justify the need to characterize the in vivo neurobiological actions of estrogen. To date, only one study has ex- CEE ϭ conjugated equine estrogens; HT ϭ hormone therapy; BP ϭ blood pressure; RBC ϭ red blood cells. Figure 1 . Area in region of interest showing differential activation between three groups. Plots of cluster activation at global maxima suggest that estradiol-and conjugated equine estrogen (CEE)-exposed groups exhibit greater signal change than hormone therapy (HT)-naive group. The statistical comparison is overlaid on a template brain. Orientation for coronal slices located at y coordinates -20 to -35; the left side of the brain is on the left side of the image. Orientation for sagittal slice is at x coordinate ϭ 26. Smaller figure depicts activation for three groups of women (HT naive or estradiol or CEE exposed) represented by eigenvalues from a 2-mm radius cluster centered at maximum of right hippocampal cluster (x, y, z: 26, Ϫ20, Ϫ16). Displayed are boxplots (minimum, 25th percentile; median, 75th percentile; maximum, in black) superimposed on 95% CIs of the medians (gray).
amined the effects of estrogen intervention on brain activation with fMRI, finding short-term estrogen treatment enhanced activation of the neural network underlying working memory. 8 Our comparison of women either naive or exposed to one of two forms of HT revealed a difference in signal change bilaterally in the medial temporal lobes, including the right hippocampus ( figure 1 ), suggesting that both forms of HT enhanced the neuronal response. It is possible that HT-exposed women may be evidencing a compensatory increased activation 9 ; however, our previous findings using this simple encoding task found increased hippocampal signal change reflected a healthy state. 4, 5 On the other hand, cognitive analyses suggested that despite their "healthy" fMRI response, women exposed to opposed CEE demonstrated worse cognitive performance than women naive to HT and those exposed to opposed estradiol. To our knowledge, these are the first data to support the WHIMS find-ings of detrimental cognitive effects associated with opposed CEE therapy. It may be that CEE is associated with hippocampal neuroprotection; however, other cumulative effects of CEE may be detrimental. Further study with larger samples is needed to elucidate the CNS effects of HT.
The foremost limitation with our study is the small sample size, especially for women exposed to opposed estradiol. Furthermore, this is not a randomized trial. We were unable to control for length of exposure to HT or other factors that may influence estrogen's effects. Notably, four women were on active treatment at the time of the scan, a factor that could have affected their blood oxygenation leveldependent signal. However, excluding the four women on HT revealed a similar pattern of neuronal activation in a more general comparison of HT-naive and HT-exposed groups. In total, these factors may compromise the comparability of groups and generalizability of the data. 
